Drugs in the Treatment of Dystonia, Multisystem Atrophy, and Non-Parkinson Tremor

2020 ◽  
pp. 1-16
Author(s):  
Wolfgang H. Jost ◽  
Joerg Müller
Keyword(s):  
Multisystem Atrophy

Neuroradiology case of the day. Multisystem atrophy.

1996 ◽  
Vol 167 (1) ◽  
pp. 263-263
Author(s):  
J E Dix ◽  
W F Marx ◽  
W S Cail
Keyword(s):  
Multisystem Atrophy

scholarly journals Magnetic resonance morphometry of the brain in different variants of multisystem atrophy

2020 ◽  
Vol 11 (1) ◽  
pp. 33-37
Author(s):  
E. V. Iskhakova ◽  
A. G. Trufanov ◽  
A. A. Yurin ◽  
A. S. Lepekhina ◽  
A. Yu. Efimtsev ◽  
...  
Keyword(s):  
Magnetic Resonance ◽  
Multisystem Atrophy ◽  
The Brain

Lithium in Multisystem Atrophy: Lack of Efficacy and Safety Issues (P06.073)

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. P06.073-P06.073
Author(s):  
F. Sacca ◽  
A. Marsili ◽  
A. Brunetti ◽  
R. Carbone ◽  
G. De Michele ◽  
...  
Keyword(s):  
Efficacy And Safety ◽  
Safety Issues ◽  
Multisystem Atrophy

Multisystem Atrophy Made Worse by Lithium Treatment in a Hospice Patient

2012 ◽  
Vol 29 (7) ◽  
pp. 570-573 ◽  
Author(s):  
Ellen Babinsky ◽  
Richard S. Levene
Keyword(s):  
Bipolar Disorder ◽  
Cognitive Impairment ◽  
Clinical Course ◽  
Lithium Treatment ◽  
Unknown Etiology ◽  
Lithium Toxicity ◽  
Adult Onset ◽  
Presenting Symptoms ◽  
Multisystem Atrophy ◽  
Hospice Patient

Multisystem atrophy is a neurologic condition defined as an adult-onset, progressive, neurodegenerative disease of unknown etiology. It carries a multisystem clinical course, including autonomic, urogenital, cerebellar, and parkinsonian features. Lithium toxicity, classically manifesting as increased thirst, polyuria, gastric distress, weight gain, tremor, fatigue, and mild cognitive impairment, can present in a similar manner. 1 We would like to present a patient diagnosed with progressive neurologic features typical of multisystem atrophy that also had bipolar disorder and had been taking lithium for many years. Despite normal lithium levels, it appeared as though a subclinical lithium toxicity was manifesting in the patient, and once lithium was discontinued, the patient was discharged from hospice with significant improvement in his presenting symptoms.

scholarly journals Rare presentation of hallucinations in cerebellar multisystem atrophy

2020 ◽  
Vol 9 (1) ◽  
pp. 285
Author(s):  
Galina L. D'Souza ◽  
Priya Nayak K.
Keyword(s):  
Cerebellar Ataxia ◽  
Psychotic Disorder ◽  
Rare Case ◽  
Neurodegenerative Disorder ◽  
Neuropsychiatric Symptoms ◽  
Psychotic Symptoms ◽  
Rare Presentation ◽  
Multisystem Atrophy ◽  
Medical Disorders ◽  
Cerebellar Type

Psychotic symptoms are seen in patients with medical disorders. Multisystem atrophy (MSA) is a neurodegenerative disorder which is rapidly progressive. It can occur in two forms; one with parkinsonian features (MSA-P) and other with cerebellar ataxia (MSA-C). The prevalence of this disorder is about 2-5 per 1,00,000 individuals. Neuropsychiatric symptoms like depression, apathy and anxiety have been reported frequently in these patients but there are isolated reports describing hallucinations in patients with MSA. It is mostly seen in patients with parkinsonian type of MSA rather than cerebellar type of MSA. Here we report a rare case of psychotic disorder in a patient with cerebellar type of multi-system atrophy.

Multisystem Atrophy (MSA)

2011 ◽  
pp. 1685-1685
Author(s):  
Anna DePold Hohler ◽  
Marcus Ponce de Leon
Keyword(s):  
Multisystem Atrophy
Sign in / Sign up

Export Citation Format

Share Document